Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 25, Issue suppl 3, Pages iii49-iii56
Publisher
Oxford University Press (OUP)
Online
2014-09-11
DOI
10.1093/annonc/mdu259
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
- (2014) Robert J Motzer et al. LANCET ONCOLOGY
- Radiotherapy for renal-cell carcinoma
- (2014) Gert De Meerleer et al. LANCET ONCOLOGY
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
- (2013) Brett Delahunt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- (2013) Thomas E. Hutson et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer
- (2012) Steven MacLennan et al. EUROPEAN UROLOGY
- Long-Term Oncologic Outcomes After Radiofrequency Ablation for T1 Renal Cell Carcinoma
- (2012) Sarah P. Psutka et al. EUROPEAN UROLOGY
- Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer
- (2011) Michael A.S. Jewett et al. EUROPEAN UROLOGY
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastasectomy After Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
- (2010) Jose A. Karam et al. JOURNAL OF UROLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search